Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Oncotarget Année : 2017

Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function

Résumé

The tumor suppressor BAP1 associates with ASXL1/2 to form the core Polycomb complex PR-DUB, which catalyzes the removal of mono-ubiquitin from several substrates including histone H2A. This complex also mediates the poly-deubiquitination of HCFC1, OGT and PCG1-α, preventing them from proteasomal degradation. Surprisingly, considering its role in a Polycomb complex, no transcriptional signature was consistently found among BAP1-inactivated tumor types. It was hypothesized that BAP1 tumor suppressor activity could reside, at least in part, in stabilizing proteins through its poly-deubiquitinase activity. Quantitative mass spectrometry and gene expression arrays were used to investigate the consequences of BAP1 expression modulation in the NCI-H226 mesothelioma cell line. Analysis of differentially expressed proteins revealed enrichment in cytoskeleton organization, mitochondrial activity and ROS management, while gene expression analysis revealed enrichment in the epithelial-to-mesenchymal transition pathway. Functional assessments in BAP1 inactivated, BAP1 wild-type and BAP1 catalytically dead-expressing NCI-H226 and QR mesothelioma cell lines confirmed alteration of these pathways and demonstrated that BAP1 deubiquitinase activity was mandatory to maintain these phenotypes. Interestingly, monitoring intracellular ROS levels partly restored the morphology and the mitochondrial activity. Finally, the study suggests new tumorigenic and cellular functions of BAP1 and shows for the first time the interest of studying the proteome as readout of BAP1 inactivation.
Fichier principal
Vignette du fichier
19872-286186-5-PB.pdf (4.92 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

inserm-02478605 , version 1 (14-02-2020)

Identifiants

Citer

Lucie Hébert, Dorine Bellanger, Chloé Guillas, Antoine Campagne, Florent Dingli, et al.. Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function. Oncotarget, 2017, 8 (42), pp.72513-72527. ⟨10.18632/oncotarget.19872⟩. ⟨inserm-02478605⟩
80 Consultations
87 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More